
Engineers develop portable device to detect rare mutations
A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood.

A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood.

A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According to the National Brain Tumor Society, the average survival for patients diagnosed with glioblastoma is eight months.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune response.

This tiny device can shrink dangerous blood clots. It’s called the ‘milli-spinner’ and its invention was partly an accident.

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.

Researchers gave participants face tattoos that can track when their brain is working too hard. Published in the journal Device, the study introduces a non-permanent wireless forehead e-tattoo that decodes brainwaves to measure mental strain without bulky headgear.

Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.

A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer’s and other neurological diseases, according to a study published today in Nature Biomedical Engineering.

Associate Professor Dr. Hadi Mohammadi runs the Heart Valve Performance Laboratory at UBCO’s School of Engineering. He, along with Dr. Dylan Goode, has been testing an MHV created in their lab that may—after clinical trials—supersede mechanical valves currently available for people living with heart disease.